ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Arcellx Inc

Arcellx Inc (ACLX)

80.55
2.56
(3.28%)
At close: September 18 4:00PM
80.55
0.00
( 0.00% )
After Hours: 4:02PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
80.55
Bid
77.46
Ask
83.00
Volume
672,178
78.05 Day's Range 82.97
30.88 52 Week Range 80.60
Market Cap
Previous Close
77.99
Open
78.73
Last Trade Time
16:02:26
Financial Volume
$ 54,006,719
VWAP
80.3459
Average Volume (3m)
437,689
Shares Outstanding
53,755,679
Dividend Yield
-
PE Ratio
-62.08
Earnings Per Share (EPS)
-1.32
Revenue
110.32M
Net Profit
-70.69M

About Arcellx Inc

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Arcellx Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ACLX. The last closing price for Arcellx was $77.99. Over the last year, Arcellx shares have traded in a share price range of $ 30.88 to $ 80.60.

Arcellx currently has 53,755,679 shares outstanding. The market capitalization of Arcellx is $4.19 billion. Arcellx has a price to earnings ratio (PE ratio) of -62.08.

Arcellx (ACLX) Options Flow Summary

Overall Flow

Bullish

Net Premium

11M

Calls / Puts

166.67%

Buys / Sells

60.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

ACLX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
16.959.4429347826173.680.672.533921376.20537539CS
414.2321.456574185866.3280.664.139090371.4028397CS
1227.0550.560747663653.580.64943768962.51664207CS
269.5913.514656144370.9680.647.8845140259.00271829CS
5247.55144.0909090913380.630.8852495754.30089375CS
15661.55323.9473684211980.66.03547639638.99138163CS
26061.55323.9473684211980.66.03547639638.99138163CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

ACLX Discussion

View Posts
Monksdream Monksdream 3 days ago
ACLX new 52 week high
👍️0
Monksdream Monksdream 2 months ago
ACLX under $100
👍️0
Monksdream Monksdream 5 months ago
ACLX over $30
👍️0
Monksdream Monksdream 8 months ago
ACLX new 52 week high
👍️0
Monksdream Monksdream 8 months ago
ACLX new 52 week high
👍️0
Monksdream Monksdream 8 months ago
ACLX new 52 week high
👍️0
bandit007 bandit007 2 years ago
Going beast mode into next week.
👍️0
TheyWantYourShares TheyWantYourShares 2 years ago
Nice correction coming here. New IPO at 16… company is flush with capital/cash. Moves coming and getting in now will pay off big IMHO.


Got in on the drop @average: 13.12 … 2 and 3 days ago.


$ACLX


GLTA!!



-TWYS
👍️0
crudeoil24 crudeoil24 3 years ago
Net loss of $44M > no revenues! ( over 9 month period)

ACLX
👍️0
crudeoil24 crudeoil24 3 years ago
Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer treatments, looks to raise up to $140.25 million. The company said it is offering 8.25 million shares in the IPO, which is expected to price between $15 and $17 a share. With 33.54 million shares expected to be outstanding after the IPO, the expected pricing could value the company at up to $570.24 million. The stock is expected to list on the Nasdaq under the ticker symbol "ACLX." BofA Securities, SVB Leerink, Barclays and William Blair are the lead underwriters. The company recorded a net loss of $44.30 million on no revenue during the nine months ended Sept. 30, after a loss of $23.00 million on no revenue in the same period a year ago. Arcellx is looking to go public at a time of relative investor disdain for IPOs and biotechs, as the Renaissance IPO ETF IPO, -3.27% has plunged 37.2% over the past three months and the iShares Biotechnology ETF IBB, -1.39% has tumbled 19.8%, while the S&P 500 SPX, +0.31% has slipped 3.8%.
👍️0

Your Recent History

Delayed Upgrade Clock